International Stem Cell CORP Stock: price and directors' dealings · United States · SEC (Form 4)

Follow the International Stem Cell CORP stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). The latest transaction was disclosed on 11 September 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: MAIER PAUL V. The full history is free.